Protective Effects of PGC-1α Activators on Ischemic Stroke in a Rat Model of Photochemically Induced Thrombosis
Open accessThe DOI matches its Crossref record; 103 of the 106 references it cites were found in a registry or an index; 21 of the 58 sources its claims cite were checked for support.
Abstract
The pharmacological induction and activation of peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1α), a key regulator of ischemic brain tolerance, is a promising direction in neuroprotective therapy. Pharmacological agents with known abilities to modulate cerebral PGC-1α are scarce. This study focused on the potential PGC-1α-modulating activity of Mexidol (2-ethyl-6-methyl-3-hydroxypyridine succinate) and Semax (ACTH(4–7) analog) in a rat model of photochemical-induced thrombosis (PT) in the prefrontal cortex. Mexidol (100 mg/kg) was administered intraperitoneally, and Semax (25 μg/kg) was administered intranasally, for 7 days each. The expression of PGC-1α and PGC-1α-dependent protein markers of mitochondriogenesis, angiogenesis, and synaptogenesis was measured in the penumbra via immunoblotting at Days 1, 3, 7, and 21 after PT. The nuclear content of PGC-1α was measured immunohistochemically. The suppression of PGC-1α expression was observed in the penumbra from 24 h to 21 days following PT and reflected decreases in both the number of neurons and PGC-1α expression in individual neurons. Administration of Mexidol or Semax was associated with preservation of the neuron number and neuronal expression of PGC-1α, stimulation of the nuclear translocation of PGC-1α, and increased contents of protein markers for PGC-1α activation. This study opens new prospects for the pharmacological modulation of PGC-1α in the ischemic brain.
Overview
CoChat Summary
TL;DR
In a rat model of photochemically induced focal ischemic stroke, the authors found that Mexidol and Semax reduced brain injury and were associated with preservation and activation of PGC-1α in the penumbra. Mexidol generally showed stronger effects than Semax on infarct reduction, inflammatory-cell infiltration, and PGC-1α-related protein changes.
Key findings
- In Stroke + Saline rats, the ischemic core covered 40% of the prefrontal cortex area at 1 day after PT, and the damage remained similar at 3 and 7 days; by 21 days there was a 25% retraction of the damage site with cyst formation.
- A single dose given 2 h after PT reduced the necrotic area: 1.8-fold with Mexidol and 1.6-fold with Semax versus Stroke + Saline; after the 7-day course, the damaged region at 21 days was reduced by 3.5-fold (Mexidol) and 2.4-fold (Semax) versus Stroke + Saline.
- In the penumbra, PT caused a 20% decrease in PGC-1α-immunopositive neurons at 24 h, while Mexidol and Semax maintained the total number of PGC-1α-expressing neurons at the control level and increased neurons with high/medium nuclear PGC-1α immunoreactivity; at 24 h, Mexidol raised high and medium nuclear PGC-1α by 40% and 30%, and Semax by 25% and 20% versus Stroke + Saline.
- PGC-1α-dependent markers increased after ischemia and treatment, especially at 1 day: in Stroke + Saline, NRF1 increased by 200%, TFAM by 350%, NDUFV2 by 140%, SDHA by 200%, VEGF by 250%, and SYP by 130%; Mexidol also increased NRF1 by 40%, TFAM 100%, NDUFV2 30%, SDHA 100%, VEGF 80%, SYP 20%, and SUCNR1, while Semax increased NRF1 by 20%, TFAM 50%, NDUFV2 20%, SDHA 50%, and VEGF 40%.
Methods
- Male Wistar rats (n = 96, 200–230 g, 8–9 weeks old) were assigned to four groups: Stroke + Saline, Stroke + Mexidol (100 mg/kg i/p), Stroke + Semax (25 μg/kg intranasal), and Control (n = 24 per group).
- Focal ischemic stroke was modeled by photochemically induced thrombosis in the prefrontal cortex; animals were analyzed on Days 1, 3, 7, and 21 after stroke induction.
- Outcomes included histology/morphometry of infarct core and penumbra, Western blotting for PGC-1α and related proteins, and immunohistochemistry for PGC-1α nuclear localization; group differences were tested with two-way ANOVA and Bonferroni post-hoc tests.
Limitations
- Not stated in the paper.
- Evident from the text: the study is an animal model in male rats, so direct clinical applicability to human stroke is not established in this paper.
- Evident from the text: the experiments used a photochemically induced thrombosis model in the prefrontal cortex, which may not capture all features of human ischemic stroke.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3 Dynamics of the development of ischemic damage of the prefrontal brain cortex in rats during the 7-day course of Mexidol or Semax treatment and 14 days after drug withdrawal. Photographs of rat prefrontal cortex slices were taken in the region with maximal cortex damage (at the level of 4.2 mm from the bregma) [62]. The slices were stained with hematoxylin and eosin (H&E). The border of the infarct area is marked with a dashed line. Under each image, the values of the sum of the damaged areas in both hemispheres are indicated, and the damaged area as a percentage of the prefrontal cortex is indicated in brackets. * p < 0.05 denotes a significant difference from the Stroke + Saline group at the appropriate time period; # p < 0.05 denotes a significant difference between the Stroke + Mexidol with Stroke + Semax groups at the appropriate time periods based on a two-way ANOVA with Bonferroni’s post-hoc multiple comparison test.](https://figures.cochat.ai/paper-figures/00cee2eacfa24336a99a7709bd5dc61d/protective-effects-of-pgc-1-activators-on-ischemic-stroke-in-a-rat-model-of-figure-3.jpg)




Verification
Claims the paper makes
8 Valid · 5 Not valid · 11 Not checked · 89 Own results and interpretations
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Improvement of microcirculation and penumbral tissue oxygenation mediated by the drugs Mexidol and Semax may be crucial to reverse the HIF-1α-dependent blockade of PGC-1α expression [14,86,87].”
§ Protective Effects of PGC-1α Activators on Ischemic Stroke in a Rat Model of Photochemically Induced Thrombosis > 4. Discussion
What the sources say
- Could not verifycites [14] Villena, 2008, ERRα: A metabolic function for the oldest orphan, Trends Endocrinol. Metab. sourceExperimental — accuracy not yet measured
The section ‘Regulation of ERRα: the roles of PGC-1α and PGC-1β’ discusses PGC-1α in energy metabolism, but does not address HIF-1α-dependent suppression of its expression. Searches for HIF-1α, hypoxia, oxygenation, Mexidol, Semax, and penumbral microcirculation found no passage supporting the proposed mechanism; page numbers were unavailable in our copy. (LLM, conf=0.75)
- Not checked — no full text of the sourcecites [86] Dringen, 2000, Metabolism and functions of glutathione in brain, Prog. Neurobiol. source
- Could not verifycites [87] Julier, 2017, Promoting tissue regeneration by modulating the immune system, Acta Biomater. sourceExperimental — accuracy not yet measured
The supplied passages and further searches for Mexidol, Semax, penumbral oxygenation, HIF-1α, and PGC-1α found no discussion of the claimed drug effects or expression mechanism. The closest passages, in §§3.4 and 3.6 (page numbers unavailable), concern immune-mediated tissue repair rather than this claim. (LLM, conf=0.76)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“HIF-1α is also a key factor in suppressing mitochondrial biogenesis and PGC-1α expression through mechanisms of negative regulation of the transcription factor MYC and the MYC-dependent transcription factors (PPARs and ERRs) that activate the PGC-1α gene [14,86,87].”
§ Protective Effects of PGC-1α Activators on Ischemic Stroke in a Rat Model of Photochemically Induced Thrombosis > 4. Discussion
What the sources say
- Partly supportedcites [14] Villena, 2008, ERRα: A metabolic function for the oldest orphan, Trends Endocrinol. Metab. sourceExperimental — accuracy not yet measured
The sections on regulation and cellular function of ERRα (page not specified) link PGC-1α and ERRα to mitochondrial biogenesis. They do not establish the attributed mechanism: HIF-1α suppressing MYC, MYC-dependent PPARs or ERRs activating the PGC-1α gene, or the resulting suppression of PGC-1α expression. The paper instead describes PGC-1α as regulating ERRα expression and ERRα as a downstream effector of PGC-1α. (LLM, conf=0.78)
- Not checked — no full text of the sourcecites [86] Dringen, 2000, Metabolism and functions of glutathione in brain, Prog. Neurobiol. source
- Could not verifycites [87] Julier, 2017, Promoting tissue regeneration by modulating the immune system, Acta Biomater. sourceExperimental — accuracy not yet measured
The passages from §§2.3 and 3.4.3 discuss immune-cell activity and inflammatory signaling, not the proposed mitochondrial mechanism. Searches of the full-text copy for HIF-1α, PGC-1α, mitochondrial biogenesis, and MYC found no passage addressing the claim. (LLM, conf=0.76)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
None of the sources cited for this claim have been checked yet.
In the paper
“In 2004, when the highly specific succinate receptor SUCNR1/GPR91 was discovered, it became evident that succinate plays a regulatory signaling role in the formation of adaptive mechanisms of tolerance to ischemia/hypoxia at the cellular, tissue, and organismic levels [59,99,100,101].”
§ Protective Effects of PGC-1α Activators on Ischemic Stroke in a Rat Model of Photochemically Induced Thrombosis > 4. Discussion
What the sources say
- Not checked — no full text of the sourcecites [59] Hamel, 2014, G-protein–coupled receptor 91 and succinate are key contributors in neonatal postcerebral hypoxia-ischemia recovery, Arterioscler. Thromb. Vasc. Biol. source
- Not checked yetcites [99] Hasegawa, A., and Furuhama, K. (1998). Atlas of the Hematology of the Laboratory Rat, Elsevier Science Ltd.. [1st ed.].
- Could not verifycites [100] Baghirova, 2015, Sequential fractionation and isolation of subcellular proteins from tissue or cultured cells, MethodsX sourceExperimental — accuracy not yet measured
The Method details passages describe subcellular protein fractionation, including work with isolated rat hearts, but do not address succinate signaling or tolerance to ischemia or hypoxia. Searches for SUCNR1/GPR91, the 2004 receptor discovery, and succinate-mediated adaptation found no relevant passage in our copy. (LLM, conf=0.76)
- Not checked — no full text of the sourcecites [101] Kurien, B.T., and Scofield, R.H. (2015). Two-dimensional gel-based protein standardization verified by western blot analysis. Western Blotting. Methods and Protocols, Springer Science + Business Media. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“In the middle cerebral artery occlusion model, the delayed administration of Mexidol 6 h after ischemia induction and for 6 subsequent days resulted in a 30% decrease in brain damage [88].”
§ Protective Effects of PGC-1α Activators on Ischemic Stroke in a Rat Model of Photochemically Induced Thrombosis > 4. Discussion
What the sources say
- Could not verifycites [88] Igarashi, 2016, A key role of PGC-1a transcriptional coactivator in production of VEGF by a novel angiogenic agent COA-Cl in cultured human fibroblasts, Physiol. Rep. sourceExperimental — accuracy not yet measured
The Materials and Methods section describes COA-Cl treatment of cultured human fibroblasts, and the Results report VEGF expression rather than brain injury. Searches for Mexidol, middle cerebral artery occlusion, delayed dosing, and a 30% reduction found no passage addressing the cited claim. The indexed passages provide no page numbers. (LLM, conf=0.76)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“The ischemic suppression of translational processes is accompanied by the downregulation of peptide neurohormones and neurotransmitters, as well as their receptors [49,103].”
§ Protective Effects of PGC-1α Activators on Ischemic Stroke in a Rat Model of Photochemically Induced Thrombosis > 4. Discussion
What the sources say
- Could not verifycites [49] Medvedeva, 2014, The peptide Semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: Genome-wide transcriptional analysis, BMC Genom. sourceExperimental — accuracy not yet measured
The Results section, “Molecular functions of the protein products of genes with altered expression under Semax treatment” (page unavailable), reports decreased expression of some transmembrane-receptor genes after Semax treatment in ischemic rats. It does not attribute that decrease to ischemia itself. Searches for translation, neurohormones, neurotransmitters, and their receptors found no passage linking ischemic suppression of translation to the claimed downregulation. (LLM, conf=0.75)
- Not checked — no full text of the sourcecites [103] Mullen, 1992, NeuN, a neuronal specific nuclear protein in vertebrates, Development source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
52 more claims
Create a free account to see all 113 claims and to verify the 5 references still open.
- Probably not a substantial claim. 9
- It may state two separate claims as one. 49
Citations
Cites
Cellular Scaling Rules for the Brains of Marsupials: Not as “Primitive” as Expected
Dos Santos, S. E., Porfirio, J., da Cunha, F. B., Manger, P. R., Tavares, W., Pessoa, L., Raghanti, M. A., Sherwood, C. C., & Herculano-Houzel, S. (2017) · Brain, Behavior and Evolution · doi:10.1159/000452856 · Cited by 2,642
Regulation of angiogenesis by hypoxia: role of the HIF system
Pugh, C. W., & Ratcliffe, P. J. (2003) · Nature Medicine · doi:10.1038/nm0603-677 · Cited by 2,520 · cited 1×
“The supernatant (the cytoplasmic extract) [67] containing the target proteins was collected after centrifugation (30 min, 14,000× g; 4 ◦C), mixed with the loading buffer (4× Laemmli Sample Buffer), incubated for 5 min at 95 ◦C, and stored at −80 ◦C.”
MethodNeuN, a neuronal specific nuclear protein in vertebratesxs
Mullen, R. J., Buck, C. R., & Smith, A. M. (1992) · Development · doi:10.1242/dev.116.1.201 · Cited by 2,351
St-Pierre, J., Drori, S., Uldry, M., Silvaggi, J. M., Rhee, J., Jäger, S., Handschin, C., Zheng, K., Lin, J., Yang, W., et al. (2006) · Cell · doi:10.1016/j.cell.2006.09.024 · Cited by 2,233
Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases
Tang, Y., & Le, W. (2016) · Molecular Neurobiology · doi:10.1007/s12035-014-9070-5 · Cited by 2,190 · cited 1×
“Intranasal administration of Semax over the 7-day treatment course resulted in a 25% decrease of infarct volume in the prefrontal cortex and cognitive function recovery over the long term [45,81].”
BackgroundFunction and regulation of CREB family transcription factors in the nervous system
Lonze, B. E., & Ginty, D. D. (2002) · Neuron · doi:10.1016/s0896-6273(02)00828-0 · Cited by 2,127 · cited 1×
“The sustained suppression of PGC-1α in ischemic brain tissue without reperfusion was reported in models of permanent occlusion in the middle cerebral artery, in an endothelin model of stroke, and in chronic cerebral hypoperfusion [82,83].”
BackgroundPuigserver, P., & Spiegelman, B. M. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0012 · Cited by 2,076 · cited 1×
“In the nervous system, synaptic activity and calcium influx through GluRs induce the activation of Ca2+calmodulin (CaM)-dependent kinases, Ras/MAPK, and AMPK signaling cascades, which increase the expression, the stability, and the activity of PGC-1α [8,30,33,34] (Figure 1).”
BackgroundMetabolism and functions of glutathione in brain
Dringen, R. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00060-x · Cited by 1,702 · cited 2×
“Improvement of microcirculation and penumbral tissue oxygenation mediated by the drugs Mexidol and Semax may be crucial to reverse the HIF-1α-dependent blockade of PGC-1α expression [14,86,87].”
BackgroundOxidative metabolism and PGC-1β attenuate macrophage-mediated inflammation
Vats, D., Mukundan, L., Odegaard, J. I., Zhang, L., Smith, K. L., Morel, C. R., Greaves, D. R., Murray, P. J., & Chawla, A. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.05.011 · Cited by 1,369
PGC-1α: a key regulator of energy metabolism
Liang, H., & Ward, W. F. (2006) · Advances in Physiology Education · doi:10.1152/advan.00052.2006 · Cited by 1,245
Research works printed but not linked: 3
- Paxinos, G., and Watson, C. (1998). The Rat Brain in Stereotaxic Coordinates, Academic Press. [4th ed.].
- Parker, G.A., and Picut, C.A. (2016). Atlas of Histology of the Juvenile Rats, Elsevier. [1st ed.].
- Hasegawa, A., and Furuhama, K. (1998). Atlas of the Hematology of the Laboratory Rat, Elsevier Science Ltd.. [1st ed.].
Cited by
Zhang, C., Lan, X., Wang, Q., Zheng, Y., Cheng, J., Han, J., Li, C., Cheng, F., & Wang, X. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103622 · Cited by 78
Age-Related Alterations in Immune Function and Inflammation: Focus on Ischemic Stroke
Chen, Q., Wu, M., Tang, Q., Yan, P., & Zhu, L. (2023) · Aging and Disease · doi:10.14336/ad.2023.0721-1 · Cited by 43
Wang, H., Wu, M., Zhu, M.-M., Qin, Y., Wang, K.-Q., Wu, C.-Y., Zhang, R., Wang, Y., Zhou, C., Luo, S., et al. (2025) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-025-00762-2 · Cited by 12
“Recently, the significance of PGC-1α in regulating inflammation, thrombosis, and oxidative stress in various inflammatory diseases has gained increased recognition [20–22].”
Boeva, E. A., Silachev, D. N., Yakupova, E. I., Milovanova, M. A., Варнакова, Л. А., Kalabushev, S. N., Denisov, S., Antonova, V. V., Рыжков, И. А., Николаевич, Л. К., et al. (2023) · General Reanimatology · doi:10.15360/1813-9779-2023-3-46-53 · Cited by 7
Self-citationThe role of PGC-1α in brain injury: mechanisms and therapeutic potential
Dai, X., Song, W., Wu, J., Gao, S., Liu, L., Wu, H., Zhang, L.-Q., Liu, D.-Q., Zhou, Y., Tang, Y., et al. (2025) · Brain Hemorrhages · doi:10.1016/j.hest.2025.07.006 · Cited by 8
Metadata
- Authors
- Shakova, F. M., Kirova, Y. I., Silachev, D. N., Romanova, G. A., & Morozov, S. G.
- Affiliations
- Research Institute of General Pathology and Pathophysiology, the Russian Academy of Medical Sciences (RU)
- Institute of General Pathology and Pathophysiology, Baltiyskaya Str. 8, 125315 Moscow, Russia
- Peoples' Friendship University of Russia (RU)
- Corresponding author
- Shakova, Fatima M.
- Venue
- Brain Sciences
- Publisher
- MDPI AG
- Published
- 2021-03-04
- Volume
- 11
- Issue
- 3
- Pages
- 325
- ISSN
- 2076-3425 (ISSN-L)
- PMC
- PMC8002020
- OpenAlex
- W3134269086
- Cited by
- 13
- References
- 106
- Citations by year
- 2026: 2 · 2025: 6 · 2023: 2 · 2022: 2 · 2021: 1
- FWCI
- 0.52
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Brain Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- This work was funded by the Institute of General Pathology and Pathophysiology (Federal Budget funding), was performed within the framework of the research "Pathogenetic mechanisms of neurodegenerative diseases and the development of their complex therapy (0520-2019-0029)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- PGC-1α, ischemic stroke, photochemically induced thrombosis, Mexidol, Semax, neuroprotection, ischemic penumbra, mitochondrial biogenesis, angiogenesis, synaptogenesis, prefrontal cortex
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Protective Effects of PGC-1α Activators on Ischemic Stroke in a Rat Model of Photochemically Induced Thrombosis. https://app.cochat.ai/papers/10.3390/brainsci11030325
- The paper
- Shakova, F. M., Kirova, Y. I., Silachev, D. N., Romanova, G. A., & Morozov, S. G. (2021). Protective Effects of PGC-1α Activators on Ischemic Stroke in a Rat Model of Photochemically Induced Thrombosis. Brain Sciences. https://doi.org/10.3390/brainsci11030325
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.